Boeringer-Ingelheim Pharmaceuticals, Inc.

Member Type: Large Biotech/Pharmaceutical Companies

Boehringer Ingelheim has launched a campaign to educate healthcare providers about biomarker testing to personalize treatment for non-small cell lung cancer patients. Learn more about the "Let's Test" campaign here.

Join Today

Contact Mary Bordoni, Director, Membership & Development, for information about joining the Coalition.

Download a Member List